TY  - CONF

T1  - Safety of oral ibandronate and intravenous zoledronic acid in breast cancer patients with metastatic bone disease

JO  - BREAST CANCER RESEARCH AND TREATMENT

PY  - 2005/01/01

AU  - Body JJ

AU  - Lichinitser MR

AU  - Tjulandin SA

AU  - Coleman RE

AU  - Bergstrom B

ED  - 

VL  - 94

SP  - S260

EP  - S260

Y2  - 2025/10/10

ER  -